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tion and cross linking are described. The hydrophilic 
core itself may be degradable, thus combining the core 
and extension functions. Macroners are polymerized 
using free radical initiators under the influence of long 
wavelength ultraviolet light, visible light excitation or 
thermal energy. Biodegradation occurs at the linkages 
within the extension oligomers and results in fragments 
which are non-toxic and easily removed from the body. 
Preferred applications for the hydrogels include pre 
vention of adhesion formation after surgical proce 
dures, controlled release of drugs and other bioactive 
species, temporary protection or separation of tissue 
surfaces, adhering of sealing tissues together, and pre 
venting the attachment of cells to tissue surfaces. 
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PHOTOPOLYMERZABLE BODEGRADABLE 
HYDROGELS ASTISSUE CONTACTING 
MATER ALS AND CONTROLLED-RELEASE 
CARRIERS 
FIELD OF THE INVENTION 
The present invention relates to photopolymerizable 
biodegradable hydrogels for use as tissue adhesives and 
in controlled drug delivery. 
BACKGROUND OF THE INVENTION 
This is a continuation-in-part of U.S. patent applica 
tion No. 07/843,485, filed Feb. 28, 1992 now abandoned, 
entitled "Photopolymerizable Biodegradable Hydro 
gels as Tissue Contacting Materials and Controlled 
Release Carriers' by Jeffrey A. Hubbell, Chandrashek 
har P. Pathak, and Amarpreet S. Sawhney and a con 
tinuation-in-part of U.S. Ser. No. 07/598,880 filed Oct. 
15, 1990 and its divisional, U.S. Ser. No. 07/740,703, 
filed Aug. 5, 1991, by Jeffrey A. Hubbell and Amar 
preet S. Sawhney. 
Hydrogels as Controlled-release Carriers 
Biodegradable hydrogels can be carriers for biologi 
cally active materials such as hormones, enzymes, anti 
biotics, antineoplastic agents, and cell suspensions. 
Temporary preservation of functional properties of a 
carried species, as well as controlled release of the spe 
cies into local tissues or systemic circulation, are possi 
ble. Proper choice of hydrogel macromers can produce 
membranes with a range of permeability, pore sizes and 
degradation rates suitable for a variety of applications in 
surgery, medical diagnosis and treatment. 
Adhesives and Sealers 
Fibrin gels have been used extensively in Europe as 
sealants and adhesives in surgery (Thompson et al., 
1988, “Fibrin Glue: A review of its preparation, effi 
cacy, and adverse effects as a topical hemostat,” Drug 
Intell and Clin. Pharm., 22:946; Gibble et al., 1990, 
(1990), “Fibrin glue: the perfect operative sealant?” 
Transfusion, 30(8):741). However, they have not been 
used extensively in the United States due to concerns 
relating to disease transmission from blood products. 
Synthetic polymers have been explored as adhesives 
(Lipatova, 1986, "Medical polymer adhesives,” Ad 
vances in Polymer Science 79:65-93), but these materi 
als have been associated with local inflammation, cyto 
toxicity, and poor biocompatibility. 
Prevention of Postoperative Adhesions. 
Formation of post-surgical adhesions involving or 
gans of the peritoneal cavity and the peritoneal wall is a 
frequent and undesirable result of abdominal surgery. 
Surgical trauma to the tissue caused by handling and 
drying results in release of a serosanguinous (protein 
aceous) exudate which tends to collect in the pelvic 
cavity (Holtz, G., 1984). If the exudate is not absorbed 
or lysed within this period it becomes ingrown with 
fibroblasts, and subsequent collagen deposition leads to 
adhesion formation. 
Numerous approaches to elimination of adhesion 
formation have been attempted, with limited success in 
most cases. Approaches have included lavage of the 
peritoneal cavity, administration of pharmacological 
agents, and the application of barriers to mechanically 
separate tissues. For example, Boyers et al., (1988) "Re 
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2 
duction of postoperative pelvic adhesions in the rabbit 
with Gore-Tex surgical membrane,' Fertil. Steril, 
49:1066, examined Gore-Tex surgical membranes in the 
prevention of adhesions. For a review of adhesion pre 
vention, see Holtz (1984) “Prevention and management 
of peritoneal adhesions,” Fertil. Steril, 41:497-507. 
However, none of these approaches has been cost effec 
tive and effective in in vivo studies. 
Solutions of Poloxamer 407 have been used for the 
treatment of adhesions, with some success. Poloxamer is 
a copolymer of ethylene oxide and propylene oxide and 
is soluble in water; the solutions are liquids at room 
temperature. Steinleitner et al. (1991) “Poloxamer 407 
as an Intraperitoneal Barrier Material for the Preven 
tion of Postsurgical Adhesion Formation and Reforma 
tion in Rodent Models for Reproductive Surgery,” 
Obstetrics and Gynecology, 77(1):48 and Leach et al. 
(1990) “Reduction of postoperative adhesions in the rat 
uterine horn model with poloxamer' 407, Am. J. Obstet, 
Gynecol, 162(5):1317, examined Poloxamer solutions in 
peritoneal adhesion models and observed statistically 
significant reductions in adhesions; however, they were 
unable to eliminate adhesions, perhaps because of lim 
ited adhesion and retention on the injury site. 
Oxidized regenerated cellulose has been used exten 
sively to prevent adhesions and is an approved clinical 
product, trade-named Interceed TCY. This barrier ma 
terial has been shown to be somewhat effective in rab 
bits (Linsky et al., 1987 "Adhesion reduction in a rabbit 
uterine horn model using TC-7,' J. Reprod. Med., 32:17; 
Diamond et al., 1987 "Pathogenesis of adhesions forma 
tion/reformation: applications to reproductive sur 
gery,” Microsurgery, 8:103) and in humans (Interceed 
(TC7) Adhesion Barrier Study Group, 1989). It was 
shown to be more effective if pretreated with heparin, 
but was still unable to completely eliminate adhesions 
(Diamond et al., 1991 "Synergistic effects of INTER 
CEED(TC7) and heparin in reducing adhesion forma 
tion in the rabbit uterine horn model,” Fertility and 
Sterility, 55(2):389). 
In summary, several lavage/drug/material ap 
proaches have been explored, but none of these ap 
proaches has been able to eliminate adhesions. An ideal 
material barrier would not evoke an adhesion response 
itself, stay in place without suturing (Holtz et al., 1982 
“Adhesion induction by suture of varying tissue reactiv 
ity and caliber,” Int. J. Ferti, 27:134), degrade over a 
few weeks' time, effectively reduce adhesions to very 
low extent, and be capable of delivering a drug to the 
local site of application for several days' time. None of 
the approaches developed and described to date meet 
these requirements. 
Synthetic Biodegradable Polymers 
The field of biodegradable polymers has developed 
rapidly since the synthesis and biodegradability of poly 
lactic acid was first reported by Kulkarni et al., 1966 
"Polylactic acid for surgical implants,” Arch. Surf, 
93:839. Several other polymers are known to biode 
grade, including polyanhydrides and polyorthoesters, 
which take advantage of labile backbone linkages, as 
reported by Domb et al., 1989 Macromolecules, 22:3200; 
Heller et al., 1990 Biodegradable Polymers as Drug Deliy 
ery Systems, Chasin, M. and Langer, R., Eds., Dekker, 
N.Y., 121-161. Since it is desirable to have polymers 
that degrade into naturally occurring materials, 
polyaminoacids have been synthesized, as reported by 
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Miyake et al., 1974, for in vivo use. This was the basis 
for using polyesters (Holland et al., 1986 Controlled 
Release, 4:155-180) of a-hydroxy acids (viz., lactic acid, 
glycolic acid), which remain the most widely used bio 
degradable materials for applications ranging from clo 
sure devices (sutures and staples) to drug delivery sys 
tems (U.S. Pat. No. 4,741,337 to Smith et al.; Spilizew 
ski et al., 1985 "The effect of hydrocortisone loaded 
poly(dl-lactide) films on the inflammatory response,’ J. 
Control. Rel. 2:197-203). 
The time required for a polymer to degrade can be 
tailored by selecting appropriate monomers. Differ 
ences in crystallinity also alter degradation rates. Due to 
the relatively hydrophobic nature of these polymers, 
actual mass loss only begins when the oligomeric frag 
ments are small enough to be water soluble. Hence, 
initial polymer molecular weight influences the degra 
dation rate. 
Degradable polymers containing water-soluble poly 
mer elements have been described. Sawhney et al., 
(1990) "Rapidly degraded terpolymers of dil-lactide, 
glycolide, and e-caprolactone with increased hydrophi 
licity by copolymerization with polyethers,’ J. Biomed. 
Mater. Res. 24:1397-1411, copolymerized lactide, 
glycolide and a-caprolactone with PEG to increase its 
hydrophilicity and degradation rate. U.S. Pat. No. 
4,716,203 to Casey et al. (1987) synthesized a PGA 
PEG-PGA block copolymer, with PEG content rang 
ing from 5-25% by mass. U.S. Pat. No. 4,716,203 to 
Casey et al. (1987) also reports synthesis of PGA-PEG 
diblock copolymers, again with PEG ranging from 
5-25%. U.S. Pat. No. 4,526,938 to Churchill et al. 
(1985) described non-crosslinked materials with MW in 
excess of 5,000, based on similar compositions with 
PEG; although these materials are not water soluble. 
Cohn et al. (1988) J. Biomed. Mater. Res. 22:993-1009 
described PLA-PEG copolymers that swell in water up 
to 60%; these polymers also are not soluble in water, 
and are not crosslinked. The features that are common 
to these materials is that they use both water-soluble 
polymers and degradable polymers, and that they are 
insoluble in water, collectively swelling up to about 
60%. 
Degradable materials of biological origin are well 
known, for example, crosslinked gelatin. Hyaluronic 
acid has been crosslinked and used as a degradable 
swelling polymer for biomedical applications (U.S. Pat. 
No. 4,987,744 to della Valle et al., U.S. Pat. 4,957,744 to 
Della Valle et al. (1991) “Surface modification of poly 
meric biomaterials for reduced thrombogenicity,” 
Polym. Mater. Sci. Eng., 62:731-735). 
Use of Biodegradable Materials for Controlled Drug 
Release. 
Most hydrophilic drugs are mechanically dispersed as 
suspensions within solutions of biodegradable polymers 
in organic solvents. Protein and enzyme molecular con 
formations are frequently different under these circum 
stances than they would be in aqueous media. An en 
zyme dispersed in such a hydrophobic matrix is usually 
present in an inactive conformation until it is released 
into the surrounding aqueous environment subsequent 
to polymer degradation. Additionally, some proteins 
may be irreversibly denatured by contact with organic 
solvents used in dispersing the protein within the poly 
e. 
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Polymer Synthesis, Degradation and Local Synthesis 
Rapidly-degrading polymers currently suggested for 
short-term macromolecular drug release may raise local 
concentrations of potentially hazardous acidic degrada 
tion byproducts. Further, all biodegradable synthetic 
polymers reported thus far can only be processed inor 
ganic solvents and all biodegradable polymers are syn 
thesized under conditions which are not amenable to 
polymerization in vivo. Thus, it has not been possible to 
make implantable materials as precisely conformed bar 
riers, shaped articles, or membranes capable of deliver 
ing bioactive materials to the local tissue. 
It is therefore an object of the present invention to 
provide hydrogels which are biocompatible, biodegrad 
able, and can be rapidly formed by polymerization in 
vivo. 
It is a further object of the present invention to pro 
vide a macromer solution which can be administered 
during surgery or outpatient procedures and polymer 
ized as a tissue adhesive, tissue encapsulating medium, 
tissue support, or drug delivery medium. 
It is a still further object of the present invention to 
provide a macromer solution which can be polymerized 
in vivo in a very short time frame and in very thin, or 
ultrathin, layers. 
SUMMARY OF THE INVENTION 
Disclosed herein are biocompatible, biodegradable, 
polymerizable and at least substantially water soluble 
macromers, having a variety of uses in vivo. The ma 
cromers include at least one water soluble region, at 
least one region which is biodegradable, usually by 
hydrolysis, and at least two free radical-polymerizable 
regions. The regions can, in some embodiments, be both 
water soluble and biodegradable. The macromers are 
polymerized by exposure of the polymerizable regions 
to free radicals generated, for example, by photosensi 
tive chemicals and dyes. 
An important aspect of the macromers are that the 
polymerizable regions are separated by at least one 
degradable region to facilitate uniform degradation in 
vivo. There are several variations of these polymers. 
For example, the polymerizable regions can be attached 
directly to degradable extensions or indirectly via water 
soluble nondegradable sections so long as the polymer 
izable regions are separated by a degradable section. 
For example, if the macromer contains a simple water 
soluble region coupled to a degradable region, one 
polymerizable region may be attached to the water 
soluble region and the other attached to the degradable 
extension or region. In another embodiment, the water 
soluble region forms the central core of the macromer 
and has at least two degradable regions attached to the 
core. At least two polymerizable regions are attached to 
the degradable regions so that, upon degradation, the 
polymerizable regions, particularly in the polymerized 
gel form, are separated. Conversely, if the central core 
of the macromer is formed by a degradable region, at 
least two water soluble regions can be attached to the 
core and polymerizable regions attached to each water 
soluble region. The net result will be the same after gel 
formation and exposure to in vivo degradation condi 
tions. In still another embodiment, the macromer has a 
water soluble backbone region and a degradable region 
affixed to the macromer backbone. At least two poly 
merizable regions are attached to the degradable re 
gions, so that they are separated upon degradation, 
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resulting in gel product dissolution. In a further embodi 
ment, the macromer backbone is formed of a nonde 
gradable backbone having water soluble regions as 
branches or grafts attached to the degradable backbone. 
Two or more polymerizable regions are attached to the 
water soluble branches or grafts. In another variation, 
the backbone may be star shaped, which may include a 
water soluble region, a biodegradable region or a water 
soluble region which is also biodegradable. In this gen 
eral embodiment, the star region contains either water 
soluble or biodegradable branches or grafts with poly 
merizable regions attached thereto. Again, the polymer 
izable regions must be separated at some point by a 
degradable region. 
Examples of these macromers are PEG-oligoglyco 
lyl-acrylates. The choice of appropriate end caps per 
mits rapid polymerization and gelation; acrylates were 
selected because they can be polymerized using several 
initiating systems, e.g., an eosin dye, by brief exposure 
to ultraviolet or visible light. The poly(ethyleneglycol) 
or PEG central structural unit (core) was selected on 
the basis of its high hydrophilicity and water solubility, 
accompanied by excellent biocompatibility. A short 
oligo or poly(a-hydroxy acid), such as polyglycolic 
acid, was selected as a preferred chain extension be 
cause it rapidly degrades by hydrolysis of the ester 
linkage into glycolic acid, a harmless metabolite. Al 
though highly crystalline polyglycolic acid is insoluble 
in water and most common organic solvents, the entire 
macromer is water-soluble and can be rapidly gelled 
into a biodegradable network while in contact with 
aqueous tissue fluids. Such networks can be used to 
entrap and homogeneously disperse water-soluble 
drugs and enzymes and to deliver them at a controlled 
rate. Further, they may be used to entrap particulate 
suspensions of water-insoluble drugs. Other preferred 
chain extensions are polylactic acid, polycaprolactone, 
polyorthoesters, and polyanhydrides. Polypeptides may 
also be used. Such "polymeric' blocks should be under 
stood to include timeric, trimeric, and oligomeric 
blocks. 
These materials are particularly useful for controlled 
drug delivery, especially of hydrophilic materials, since 
the water soluble regions of the polymer enable access 
of water to the materials entrapped within the polymer. 
Moreover, it is possible to polymerize the macromer 
containing the material to be entrapped without expos 
ing the material to organic solvents. Release may occur 
by diffusion of the material from the polymer prior to 
degradation and/or by diffusion of the material from 
the polymer as it degrades, depending upon the charac 
teristic pore sizes within the polymer, which is con 
trolled by the molecular weight between crosslinks and 
the crosslink density. Deactivation of the entrapped 
material is reduced due to the immobilizing and protec 
tive effect of the gel and catastrophic burst effects asso 
ciated with other controlled-release systems are 
avoided. When the entrapped material is an enzyme, the 
enzyme can be exposed to substrate while the enzyme is 
entrapped, provided the gel proportions are chosen to 60 
allow the substrate to permeate the gel. Degradation of 
the polymer facilitates eventual controlled release of 
free macromolecules in vivo by gradual hydrolysis of 
the terminal ester linkages. 
An advantage of these macromers are that they can 
be polymerized rapidly in an aqueous surrounding. Pre 
cisely conforming, semi-permeable, biodegradable films 
or membranes can thus be formed on tissue in situ to 
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serve as biodegradable barriers, as carriers for living 
cells or other biologically active materials, and as surgi 
cal adhesives. In a particularly preferred embodiment, 
the macromers are applied to tissue having bound 
thereto an initiator, and polymerized to form ultrathin 
coatings. This is especially useful in forming coatings on 
the inside of tissue lumens such as blood vessels where 
there is a concern regarding restenosis, and in forming 
tissue barriers during surgery which thereby prevent 
adhesions from forming. 
Examples demonstrate the use of these macroners 
and polymers for the prevention of postoperative surgi 
cal adhesions in rat cecum and rabbit uterine horn mod 
els. The polymer shows excellent biocompatibility, as 
seen by a minimal fibrous overgrowth on implanted 
samples. Hydrogels for the models were gelled in situ 
from water-soluble precursors by brief exposure to long 
wavelength ultraviolet (LWI/V) light, resulting in for 
mation of an interpenetrating network of the hydrogel 
with the protein and glycosaminoglycan components of 
the tissue. The degradable hydrogel was very effective, 
both by itself and in combination with t?A, in prevent 
ing adhesions. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 shows schematically illustrated macromers of 
the present invention where is a water 
soluble core such as PEG; - - - - - is a hydrolyzably 
degradable extension such as a polyglycolide; 
====== is a polymerizable end cap or side chain 
such as an acrylate; and - - - - - - is a water-soluble 
and hydrolyzable portion such as a hyaluronate. 
FIG. 1A shows the degree of photopolymerization 
(dp) calculated and found by NMR. 
FIG. 2A shows Human foreskin fibroblasts cultured 
for six hours on glass coverslips coated with PEG 
18.5K-glycolide diacrylate (18.5KG). 
FIG. 2B shows Human foreskin fibroblasts cultured 
for six hours on glass coverslips not coated with PEG. 
FIG. 3A shows the release of BSA from a PEG 1 K 
(1000 molecular weight PEG) glycolide diacrylate with 
glycolide extensions (1 KG) hydrogel into PBS. 
FIG. 3B shows release of lysozyme from PEG 18.5K 
DL-lactide tretraacrylate (18.5KL) into PBS. 
FIG. 4A shows release of active recombinant tRA 
from a PEG 1 Klactide diacrylate (1KL) hydrogel. 
FIG. 4B shows release of active recombinant tRA 
from PEG 4K glycolide diacrylate (4KG) hydrogel. 
FIG. 4C shows release of active recombinant tRA 
from a PEG 18.5SK-glycolide diacrylate (18.5KG) 
hydrogel into PBS. 
FIG. 5A is a superior view of rabbituterine horn used 
as a control. Distorted horn anatomy with 66% adhe 
sions is evident. The horns are folded upon themselves. 
FIG. 5B is a superior view of rabbit uterine horn 
treated with a photopolymerized biodegradable hydro 
gel, PEG 18.5KL. Horn anatomy is normal, with no 
adhesion bands visible. 
FIG. 6A is an environmental scanning electron mi 
crograph (ESEM) of an untreated blood vessel follow 
ing trauma. 
FIG. 6B is an ESEM of a polymer coated blood 
vessel following trauma. 
DESCRIPTION OF THE PREFERRED 
EMBODIMENTS 
Disclosed herein are water soluble, biodegradable 
polymers formed from macromers containing both 
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water soluble regions as well as biodegradable regions 
and at least two regions which are polymerizable by 
free radical initiation, preferably by photopolymeriza 
tion using visible or long wavelength ultraviolet radia 
tion. 
The Macromers. 
In general terms, the macromers are polymers that 
are soluble in aqueous solutions, or nearly aqueous solu 
tions, such as water with added dimethylsulfoxide. 
They have three components including a biodegradable 
region, preferably hydrolyzable under in vivo condi 
tions, a water soluble region, and at least two polymer 
izable regions. Examples of these structures are shown 
in FIG. 1. 
Structure A in FIG. 1 shows a macromer having a 
water soluble region ( ), a water soluble and 
degradable component (- - - - - - ) appended to one 
another. Each has a polymerizable end cap 
(= = = = = =). Structure B shows a major water solu 
ble component or core region ( ) extended 
at either end by a degradable or hydrolyzable component 
(~~~~~~) and terminated by, at either end, a 
polymerizable component (======). Structure C 
shows a central degradable or hydrolyzable component 
(~~~~~~) bound to a water soluble component 
( ) capped at either end by a polymerizable 
component (= = = = ==). Structure D shows a central 
water soluble component ( ) with numer 
ous branches of hydrolyzable components 
(~~~~~~ ), each hydrolyzable component being 
capped with a polymerizable component 
(= = = = ==). Structure Eshows a central biodegrada 
ble, hydrolyzable component (- - - - - -) with three 
water soluble branches ( ), each water 
soluble branch being capped by a polymerizable compo 
nent (======). Structure F shows a long central 
water soluble and hydrolyzable component 
(- - - - - - ), each end being capped by a polymeriz 
able component (======). Structure G shows a 
central water soluble and hydrolyzable component 
(- - - - - - ) capped at both ends by a hydrolyzable 
component (- - - - - - ), each hydrolyzable compo 
nent being capped by a polymerizable component 
(= = = = = =). Structure H shows a central water 
soluble and degradable or hydrolyzable component 
(- - - - - - ) with end caps or branches of a polymer 
izable component (======). Structure I shows a 
central water soluble component ( ) in 
circular form with water soluble branches extended by a 
hydrolyzable component (~ - ~~~~ ) capped by a 
polymerizable component (======). Lastly, 
Structure J in FIG. 1 shows a circular water soluble core 
component ( ) with degradable branches 
(~~~~~~), each being capped by a polymerizable 
component (~ - - - - - ). 
The various structures shown in FIG. 1 are exem 
plary only. Those skilled in the art will understand 
many other possible combinations which could be uti 
lized for the purposes of the present invention. 
Used herein is the term “at least substantially water 
soluble.' This is indicative that the solubility should be 
at least about 1 g/100 ml of aqueous solution or in aque 
ous solution containing small amounts of organic sol 
vent, such as dimethylsulfoxide. By the term "polymer 
izable' is meant that the regions have the capacity to 
form additional covalent bonds resulting in macromer 
interlinking, for example, carbon-carbon double bonds 
of acrylate-type molecules. Such polymerization is 
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characteristically initiated by free-radical formation, for 
example, resulting from photon absorption of certain 
dyes and chemical compounds to ultimately produce 
free-radicals. 
In a preferred embodiment, a hydrogel begins with a 
biodegradable, polymerizable, macromer including a 
core, an extension on each end of the core, and an end 
cap on each extension. The core is a hydrophilic poly 
mer or oligomer; each extension is a biodegradable 
polymer or oligomer; and each end cap is an oligomer, 
dimer or monomer capable of cross-linking the ma 
cromers. In a particularly preferred embodiment, the 
core includes hydrophilic poly(ethylene glycol) oligo 
mers of molecular weight between about 400 and 30,000 
Da; each extension includes biodegradable poly (a- 
hydroxy acid) oligomers of molecular weight between 
about 200 and 1200 Da; and each end cap includes an 
acrylate-type monomer or oligomer (i.e., containing 
carbon-carbon double bonds) of molecular weight be 
tween about 50 and 200 Da which are capable of cross 
linking and polymerization between copolymers. More 
specifically, a preferred embodiment incorporates a 
core consisting of poly(ethylene glycol) oligomers of 
molecular weight between about 8,000 and 10,000 Da; 
extensions consisting of poly(lactic acid) oligomers of 
molecular weight about 250 Da; and end caps consisting 
acrylate moieties of about 100 Da molecular weight. 
Those skilled in the art will recognize that oligomers 
of the core, extensions and end caps may have uniform 
compositions or may be combinations of relatively short 
chains or individual species which confer specifically 
desired properties on the final hydrogel while retaining 
the specified overall characteristics of each section of 
the macromer. The lengths of oligomers referred to 
herein may vary from two mers to many, the term being 
used to distinguish subsections or components of the 
macromer from the complete entity. 
Water Soluble Regions. 
In preferred embodiments, the core water soluble 
region can consist of poly(ethylene glycol), poly(ethy 
lene oxide), poly(vinyl alcohol), poly(vinylpyrroli 
done), poly(ethyloxazoline), poly(ethylene oxide)-co 
poly(propyleneoxide) block copolymers, polysaccha 
rides or carbohydrates such as hyaluronic acid, dextran, 
heparan sulfate, chondroitin sulfate, heparin, or algi 
nate, proteins such as gelatin, collagen, albumin, oval 
bumin, or polyamino acids. 
Biodegradable Regions. 
The biodegradable region is preferably hydrolyzable 
under in vivo conditions. For example, hydrolyzable 
group may be polymers and oligomers of glycolide, 
lactide, e-caprolactone, other hydroxy acids, and other 
biologically degradable polymers that yield materials 
that are non-toxic or present as normal metabolites in 
the body. Preferred poly(a-hydroxy acid)s are poly(- 
glycolic acid), poly(DL-lactic acid) and poly(L-lactic 
acid). Other useful materials include poly(amino acids), 
poly(anhydrides), poly(orthoesters), poly(phospha 
zines) and poly(phosphoesters). Polylactones such as 
poly(e-caprolactone), poly(e-caprolactone), poly(6- 
valerolactone) and poly(gamma-butyrolactone), for 
example, are also useful. The biodegradable regions 
may have a degree of polymerization ranging from one 
up to values that would yield a product that was not 
substantially water soluble. Thus, monomeric, dimeric, 
trimeric, oligomeric, and polymeric regions may be 
used. 
5,410,016 
Biodegradable regions can be constructed from poly 
mers or monomers using linkages susceptible to biodeg 
radation, such as ester, peptide, anhydride, orthoester, 
phosphazine and phosphoester bonds. 
Polymerizable Regions. 
The polymerizable regions are preferably polymeriz 
able by photoinitiation by free radical generation, most 
preferably in the visible or long wavelength ultraviolet 
radiation. The preferred polymerizable regions are ac 
rylates, diacrylates, oligoacrylates, methacrylates, 
dimethacrylates, oligomethoacrylates, or other biologi 
cally acceptable photopolymerizable groups. 
Other initiation chemistries may be used besides 
photoinitiation. These include, for example, water and 
amine initiation schemes with isocyanate or isothiocya 
nate containing macromers used as the polymerizable 
regions. 
Photoinitiators and/or Catalysts. 
Useful photoinitiators are those which can be used to 
initiate by free radical generation polymerization of the 
macromers without cytotoxicity and within a short time 
frame, minutes at most and most preferably seconds. 
Preferred dyes as initiators of choice for LWUV or 
visible light initiation are ethyl eosin, 2,2-dimethoxy-2- 
phenyl acetophenone, other acetophenone derivatives, 
and camphorquinone. In all cases, crosslinking and pol 
ymerization are initiated among macromers by a light 
activated free-radical polymerization initiator such as 
2,2-dimethoxy-2-phenylacetophenone or a combination 
of ethyl edsin (10- to 10-2 M) and triethanol amine 
(0.001 to 0.1 M), for example. 
The choice of the photoinitiator is largely dependent 
on the photopolymerizable regions. For example, when 
the macromer includes at least one carbon-carbon dou 
ble bond, light absorption by the dye causes the dye to 
assume a triplet state, the triplet state subsequently re 
acting with the amine to form a free radical which initi 
ates polymerization. Preferred dyes for use with these 
materials include eosin dye and initiators such as 2,2- 
dimethyl-2-phenylacetophenone, 2-methoxy-2- 
phenylacetophenone, and camphorquinone. Using such 
initiators, copolymers may be polymerized in situ by 
long wavelength ultraviolet light or by laser light of 
about 514 nm, for example. 
Initiation of polymerization is accomplished by irra 
diation with light at a wavelength of between about 
200–700 nm, most preferably in the long wavelength 
ultraviolet range or visible range, 320 nm or higher, 
most preferably about 514 nm or 365 rim. 
There are several photooxidizable and photoreduc 
ible dyes that may be used to initiate polymerization. 
These include acridine dyes, for example, acriblarine; 
thiazine dyes, for example, thionine; xanthine dyes, for 
example, rose bengal; and phenazine dyes, for example, 
methylene blue. These are used with cocatalysts such as 
amines, for example, triethanolamine; sulphur com 
pounds, for example, RSO2R1; heterocycles, for exam 
ple, imidazole; enolates; organometallics; and other 
compounds, such as N-phenyl glycine. Other initiators 
include camphorquinones and acetophenone deriva 
tives. 
Thermal polymerization initiator systems may also be 
used. Such systems that are unstable at 37 C. and 
would initiate free radical polymerization at physiolog 
ical temperatures include, for example, potassium per 
sulfate, with or without tetraamethyl ethylenediamine; 
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benzoylperoxide, with or without triethanolamine; and 
ammonium persulfate with sodium bisulfite. 
APPLICATIONS FOR THE MACROMERS. 
Prevention of Surgical Adhesions. 
A preferred application is a method of reducing for 
mation of adhesions after a surgical procedure in a pa 
tient. The method includes coating damaged tissue sur 
faces in a patient with an aqueous solution of a light-sen 
sitive free-radical polymerization initiator and a ma 
cromer solution as described above. The coated tissue 
surfaces are exposed to light sufficient to polymerize the 
macroner. The light-sensitive free-radical polymeriza 
tion initiator may be a single compound (e.g., 2,2-dime 
thoxy-2-phenyl acetophenone) or a combination of a 
dye and a cocatalyst (e.g., ethyl eosin and trierhanoi 
amine). 
Controlled Drug Delivery. 
A second preferred application concerns a method of 
locally applying a biologically active substance to tissue 
surfaces of a patient. The method includes the steps of 
mixing a biologically active substance with an aqueous 
solution including a light-sensitive free-radical polymer 
ization initiator and a macromer as described above to 
form a coating mixture. Tissue surfaces are coated with 
the coating mixture and exposed to light sufficient to 
polymerize the macromer. The biologically active sub 
stance can be any of a variety of materials, including 
proteins, carbohydrates, nucleic acids, and inorganic 
and organic biologically active molecules. Specific ex 
amples include enzymes, antibiotics, antineoplastic 
agents, local anesthetics, hormones, antiangiogenic 
agents, antibodies, neurotransmitters, psychoactive 
drugs, drugs affecting reproductive organs, and oligo 
nucleotides such as antisense oligonucleotides. 
In a variation of the method for controlled drug de 
livery, the macromers are polymerized with the biologi 
cally active materials to form microspheres or nanopar 
ticles containing the biologically active material. The 
macromer, photoinitiator, and agent to be encapsulated 
are mixed in an aqueous mixture. Particles of the mix 
ture are formed using standard techniques, for example, 
by mixing in oil to form an emulsion, forming droplets 
in oil using a nozzle, or forming droplets in air using a 
nozzle. The suspension or droplets are irradiated with a 
light suitable for photopolymerization of the macromer. 
Tissue Adhesives. 
Another use of the polymers is in a method for adher 
ing tissue surfaces in a patient. The macromer is mixed 
with a photoinitiator or photoinitiator/cocatalyst mix 
ture to form an aqueous mixture and the mixture is 
applied to a tissue surface to which tissue adhesion is 
desired. The tissue surface is contacted with the tissue 
with which adhesion is desired, forming a tissue junc 
tion. The tissue junction is then irradiated until the 
macromers are polymerized. 
Tissue Coatings. 
In a particularly preferred application of these ma 
cromers, an ultrathin coating is applied to the surface of 
a tissue, most preferably the lumen of a tissue such as a 
blood vessel. One use of such a coating is in the treat 
ment or prevention of restenosis, abrupt reclosure, or 
vasospasm after vascular intervention. The photoinitia 
tor is applied to the surface of the tissue, allowed to 
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react, adsorb or bond to tissue, the unbound photoinitia 
tor is removed by dilution or rinsing, and the macromer 
solution is applied and polymerized. As demonstrated 
below, this method is capable of creating uniform poly 
meric coating of between one and 500 microns in thick- 5 
ness, most preferably about twenty microns, which does 
not evoke thrombosis or localized inflammation. 
Tissue Supports. 
The macromers can also be used to create tissue sup- 10 
ports by forming shaped articles within the body to 
serve a mechanical function. Such supports include, for 
example, sealants for bleeding organs, sealants for bone 
defects and space-fillers for vascular aneurisms. Fur 
ther, such supports include strictures to hold organs, 
vessels or tubes in a particular position for a controlled 
period of time. 
The following examples are presented to describe 
preferred embodiments and utilities of the present in 
vention and are not meant to limit the invention unless 20 
otherwise stated in the claims appended hereto. Taken 
together, the examples illustrate representative demon 
strations of the best mode of implementing the invention 
as currently understood. 
Table 1 shows the code names of the various ma- 25 
cromers synthesized in or for use in the examples, along 
with their composition in terms of the molecular weight 
of the central PEG segment and the degree of polymeri 
zation of the degradable comonomer. 
15 
TABLE 30 
Macromer Molecular Weight and Composition. 
PEG D.P. of 
molecular conomoner per Polymer 
weight Comonomer OH group Code 
20,000 glycolide 15 2OKG 35 
18,500 glycolide 2S 18.5K. 
10,000 glycolide 7 10KG 
6,000 glycolide 5 6KG 
4,000 glycolide 5 4KG 
1,000 glycolide 2 1KG 
20,000 DL-lactide 10 2OKL 40 
18,500 DL-lactide 10 18.5KL 
10,000 DL-lactide 5 10KL 
6,000 DL-lactide 5 6KL 
1,000 EDL-lactide 2 1KL 
600 DL-lactide 2 0.6.x 
600 DL-lactide -- lactide 2: CL 1 0.6KLCL 45 
caprolactone(CL) 
18,500 caprolactone 2.5 18.5KCL 
18,500 - --- 18.5KCO 
50 EXAMPLE 1: Synthesis of Photopolymerized 
Biodegradable Hydrogels. 
PEG-based Hydrogels 
PEG based biodegradable hydrogels are formed by 
the rapid laser or UV photopolymerization of water 55 
soluble macromers. Macromers, in turn, are synthesized 
by adding glycolic acid oligomers to the end groups of 
12 
PEG and then capping with acrylic end groups. The 
PEG portions of the macromers confer water solubility 
properties, and subsequent polymerization results in 
cell-nonadhesive hydrogels. Glycolic acid oligomers 
serve as the hydrolyzable fraction of the polymer net 
work, while acrylic end groups facilitate rapid polymer 
ization and gelation of the macromers. 
In preparation for synthesis, glycolide (DuPont) or 
DL-lactide (Aldrich) was freshly recrystallized from 
ethyl acetate. PEG oligomers of various molecular 
weight (Fluka or Polysciences) were dried under vac 
uum at 110° C. prior to use. Acryloyl chloride (Aldrich) 
was used as received. All other chemicals were of rea 
gent grade and used without further purification. 
Macromer Synthesis 
A 250 ml round bottom flask was flame dried under 
repeated cycles of vacuum and dry argon. 20 gm of 
PEG (molecular weight 10,000), 150 ml of xylene and 
10 ugm of stannous octoate were charged into the flask. 
The flask was heated to 60° C. under argon to dissolve 
the PEG and cooled to room temperature. 1.16 gm of 
glycolide was added to the flask and the reaction mix 
ture was refluxed for 16 hr. The copolymer was sepa 
rated on cooling and was recovered by filtration. This 
copolymer was separated on cooling and recovered by 
filtration. This copolymer (10K PEG-glycolide) was 
used directly for subsequent reactions. Other polymers 
were similarly synthesized using DL-lactide or e 
caprolactone in place of glycolide and using PEG of 
different molecular weights. 
Synthesis of Photosensitive Oligomers (Macromers): 
19 gm of 10K PEG-glycolide copolymer was dis 
solved in 150 ml methylene chloride and refluxed with 
1 ml acryloyl chloride and 1.2 ml of triethylamine for 12 
hr under an argon atmosphere. The solid triethylamine 
hydrochloride was separated by filtration and the poly 
mer was precipitated by adding the liltrate to a large 
excess of hexane. The polymer (capped by an acrylate 
at both ends) was further purified by repeated dissolu 
tion and precipitation in methylene chloride and hexane 
respectively. 
Table 2 lists certain macromers synthesized. The de 
gree of polymerization of the glycolide chain extender 
was kept low so that all polymers have approximately 
10 ester groups per chain, or about 5 per chain end. 
When these polymers are photopolymerized, a cross 
linked three-dimensional network is obtained. How 
ever, each chain segment in the resulting network needs 
just one ester bond cleaved at either end to "degrade.” 
These ester cleavages enable the chain to dissolve in the 
surrounding physiological fluid and thereby be re 
moved from the implant site. The resulting hydrolysis 
products, PEG and glycolic acid, are water soluble and 
have very low toxicity. 
TABLE 2 
Macromers Synthesized 
Mo1. Wit. % e- Calculated 
of Central % Glycolide Caprolactone Mol. Wt. of 
PEG Cain in in Extremities 
Polymer Code (daltons) Extremeties Extremities (daitons) Appearance 
0.4K 400 100 w 580 Viscous liquid 
KG 000 100 300 Viscous liquid 
4KG 4000 100 232 White solid 
OKG 10000 100 o 580 White solid 
18.5KG 18500 00 1160 Yellow solid 
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TABLE 2-continued 
Macroners Synthesized 
Mol. Wit. % e- Calculated 
of Central % Glycolide Caprolactone Mol. Wit. of 
PEG Chain in in Extremities 
Polymer Code (daltons) Extrerneties Extremities (daltons) Appearance 
co18.SKGCL 18500 50 M- 580 White solid 
Due to the presence of only a few units of glycolic 
acid per oligomeric chain, the solubility properties of 10 
the photocrosslinkable prepolymers are principally de 
termined by the central PEG chain. Solubility of the 
macromers in water and methylene chloride, both of 
which are solvents for PEG, is not adversely affected as 
long as the central PEG segment has a molecular 15 
weight of 1,000 daltons or more. Solubility data for the 
prepolymers synthesized is given in Table 3. 
TABLE 3 
SOLUBILITY DATA 2O 
Solvent KG 4 KG 10 KG 8.5 KG TMpt 
DMSO 
Acetone o 
Methanol w 
Water 
Hexane 25 
Methylene w 
Chloride 
Cold Xylene 
Hot Xylene o w 
Benzene o 
- Soluble 30 
Not soluble 
Trimethylolpropane glycolide triacrylate 
PEG chains with different degrees of polymerization 
of DL-lactide were synthesized to determine the degree 
of substitution for which water solubility of the ma 
cromers can be retained. The results are shown in Table 
4. Beyond about 20% substitution of the hydrophilic 
PEG chain with hydrophobic DL-lactoyl or acrylate 
terminals leads to the macromers becoming insoluble in 
water, though they are still soluble in organic solvents 
such as methylene chloride. 
35 
TABLE 4 
Solubility of Macromers 
D.P. of 45 
D.P. of lactide % extension of Solubility 
Ethylene Oxide or glycolide PEG chain in water 
420 4 0.1 'soluble 
420 10 2.4 soluble 
420 20 4.8 soluble 50 
420 40 9.5 soluble 
420 80 19 insoluble 
23 2 8.7 soluble 
23 4. 17.4 soluble 
23 10 43.5 insoluble 
23 40 174 insoluble 
5 4. 80 insoluble 55 
10 4. 40 soluble 
"degree of polymerization 
Photopolymerization 60 
The macromers can be gelled by photopolymeriza 
tion using free radical initiators, with the presence of 
two acrylic double bonds per chain leading to rapid 
gelation. A 23% w/w solution of various degradable 
polymers in HEPES buffered saline containing 3 ul of 65 
initiator solution (300 mg/ml of 2,2-dimethoxy-2-phe 
nyl-acetophenone in n-vinyl pyrrollidone) was used. 100 
ul of the solution was placed on a glass coverslip and 
irradiated with a low intensity long wavelength UV 
(LWUV) lamp (Blak-Ray, model 3-100A with flood). 
The times required for gelation to occur were noted and 
are given below. These times are typically in the range 
of 10 seconds. This is very significant because these 
reactions are carried out in air (UV initiated photopo 
lymerizations are slow in air as compared to an inert 
atmosphere) and using a portable, low powered long 
wave UV (LWUV) emitting source. Oxygen, which 
often inhibits free radical reactions by forming species 
which inhibit propagation, did not seem to slow down 
the polymerization. Such fast polymerizations are par 
ticularly useful in applications requiring in situ gela 
tions. This rapid gelation is believed to be due to the 
formation of micelle-like structures between the rela 
tively hydrophobic polymerizable groups on the ma 
cromer, thereby increasing the local concentration of 
the polymerizable species in aqueous solution and in 
creasing polymerization rates. 
Visible laser light is also useful for polymerization. 
Low intensity and short exposure times make visible 
laser light virtually harmless to living cells since the 
radiation is not strongly absorbed in the absence of the 
proper chromophore. Laser light can also be trans 
ported using fiber optics and can be focused to a very 
small area. Such light can be used for rapid polymeriza 
tion in highly localized regions; gelation times for se 
lected prepolymers are given in Table 5. In each case, 
0.2 ml of a 23% w/v photosensitive oligomer solution is 
mixed with ethyl eosin (10M) and trierhanoi amine 
(0.01 to 0.1 M) and the solution is irradiated with an 
argon ion laser (American argon ion laser model 905 
emitting at 514 run) at a power of 0.2-0.5W/cm2. The 
beam is expanded to a diameter of 3 mm and the sample 
is slowly scanned until gelation occurs. 
TABLE 5 
Gelation Times 
UV polymerization 
gelation time Laser Polymerization 
Polymer (mean S.D.) (s) gelation time (s) 
KG 5.3 - 4.1 <1 
4KG 4.7 - 0.5 <1 
6KG 9.3 0.5 <1 
OKG 18. 0.8 < 
10KL 7.7 - 0.5 < 
18KG 23.3 - 2 <l 
20KG 13.3 0.5 <l 
Initiator: 2,2-dimethoxy-2-phenylacetophenone, concentration 900 ppm: 0.2 ml of 
23% monomer solution in PBS 
"Argonion laser emitting at 514 nm power 3 W/cm: ethyloeosin, triethanolamine 
initiating system: 0.2 ml of 23% monomer solution in PBS 
Biodegradability 
Biodegradation of the resulting polymer network is 
an important criteria in many biomedical applications. 
Degradation of poly(glycolic acid and poly(DL-lactic 
acid) has been well documented in the literature. The 
degradation mainly takes place through the hydrolysis 
of the ester bond; the reaction is second order and 
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highly pH dependent. The rate constant at pH 10 is 7 
times faster than that at pH 7.2. 
Such facile biodegradation is surprising because poly 
(a-hydroxyacidesters) are hydrophobic and highly in 
soluble in water. Accessibility of the polymer matrix to 
the aqueous surrounding is therefore limited. However, 
because the networks are hydrogels which are swollen 
with water, all the ester linkages in the network are in 
constant contact with water with the aqueous surround 
ings. This results in a uniform bulk degradation rather 
than a surface degradation of these gels. 
Table 6 gives hydrolysis data for some of these net 
works; times listed are for complete dissolution of 60 mg 
of gel at pH 7.2 and 9.6. As noted, most of the gels 
dissolve within 12 hours at pH 9.6. 18.5k gel dissolves 
within 2.5 hr at pH 9.6 whereas 18.5KCO gel does not 
dissolve in 3 days, indicating that the lactoyl, glycoloy, 
or e-caprotactoyl ester moiety is responsible for degra 
dation of these networks. It also can be seen that the 
18.5KG gel hydrolyzes more rapidly than the 4KG gel. 
This may be due to the reduced hydrophilicity and 
higher crosslink density of the latter gel. 
TABLE 6 
Hydrolysis Data 
Time taken to 
Time taken to dissolve gel 
Oligomer used dissolve gel at at pH 7.2 
for gelation pH 9.6 (h) (days) 
4KG 6.2 5.5 
OKG 2.25 5.5 
18.5KG 2.25 >7 
18.5KCL >5 days >7 
18.5KCO >5 days >7 
Characterization of Macromers 
FTIR spectra of the prepolymers were recorded on a 
DIGILAB model FTS 15/90. The absorption at 1110 
cm 1 (characteristic C-O-C absorption of PEG) shows 
the presence of PEG segments. The strong 1760 cm 
absorption shows the presence of glycolic ester. The 
absence of hydroxyl group absorption around 3400 
cm1 and a weak acrylic double bond absorption at 
1590 cm-l shows the presence of acrylic double bonds 
at the end groups. 
500 MHz proton and 125 MHz carbon-13 spectra 
were recorded on a GE 500 instrument. The presence of 
a very strong peak at 4.9 ppm due to CH2 methylene 
from the PEG segment, a peak at 5.09. ppm due to the 
glycolic ester segment and an acrylic proton singlet at 
5.8 ppm can be easily seen from proton NMR. The 
estimated molecular weight of PEG segment and gly 
colic acid segment for different copolymers is shown in 
Table 2. The carbonyl peak at 169.39 ppm from glycolic 
acid and 36.5 ppm peak from methylene carbons from 
PEG in carbon-13 NMR are consistent with the re 
ported chemical composition of these copolymers. 
Differential scanning calorimetry (Perkin Elmer 
DSC-7) was used to characterize the oligomers for 
thermal transitions. The oligomers were heated from 
-40 C. to 200 C. at a rate of 20° C./min, presumably 
causing polymerization. The polymer was then cooled 
to -40° C. at a rate of 60 C./min and again heated to 
200 C. at a rate of 20 C/min. The first scans of biode 
gradable 18.5K PEG glycolide tetraacrylate (18.5KG) 
oligomer were compared to that of the non-degradable 
18.5K PEG tetraacrylate (18.5KCO) scan. It was seen 
that a glass transition appears in the 18.5KG at -2° C. 
while no such transition exists in the 18.5KCO. A small 
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melting peak at 140°C. was also evident due to the few 
glycolic acid mers which can crystallize to a limited 
extent. The melting peak for PEG is shifted downwards 
in 18.5KG to 57 C. from 60.7 C. for 18.5KCO. This is 
probably due to disturbance of the PEO crystalline 
structure due to the presence of the glycolic acid link 
ages. In the third cycle, by which time the oligomers 
have presumably polymerized, the Tg and Tm transi 
tions for the glycolide segments can no longer be seen, 
indicating that a crosslinked network has formed and 
the glycolic acid segments are no longer capable of 
mobility. 
The degree of polymerization (D.P.) of the degrad 
able segments added to the central water soluble PEG 
chain was determined in several cases using H NMR. 
The experimentally determined D.P. was seen to be in 
good agreement with the calculated number, as shown 
by FIG. 1A. Thus, the ring opening reaction initiated 
by the PEG hydroxyls proceeds to completion, giving 
quantitative yields. 
Determination of Total Water, Free Water Bound 
Water 
Solutions of various degradable macromers were 
made as described above. Gels in the shape of discs 
were made using a mold. 400 pil of solution was used for 
each disc. The solutions were irradiated for 2 minutes to 
ensure thorough gelation. The disc shaped gels were 
removed and dried under vacuum at 60° C. for 2 days. 
The discs were weighed (W1) and then extracted re 
peatedly with chloroform for 1 day. The discs were 
dried again and weighed (W2). The gel fraction was 
calculated as W2/W1. This data appears in Table 7. 
Subsequent to extraction, the discs were allowed to 
equilibrate with PBS for 6 hours and weighed (W3 after 
excess water had been carefully swabbed away). The 
total water content was calculated as (W3-W2) X 
100/W3. Differential scanning calorimetry (DSC) was 
used to determine the amount of free water that was 
available in the gels. A scan rate of 20 C./min was used 
and the heat capacity for the endotherm for water melt 
ing was measured (H1). The heat capacity of HBS was 
also measured (H2). The fraction of free water was 
calculated as H/H2. The residual water was assumed 
to be bound due to hydrogen bonding with the PEO 
segments. The presence of free water in the gels was 
indicated. This free water can be expected to help pro 
teins and enzymes entrapped in such gels in maintaining 
their native conformation and reducing deactivation. 
Thus these gels would appear to be suited for controlled 
release of biological micromolecules. The data for gel 
water content is summarized in Table 7 
TABLE 7 
Hydrogel Water content 
Polymer % Free 92, Bound % Total % Gel 
Code Water Water Water Contest 
1KG 68.4 14 82.3 - 2.6 61.3 : S.2 
4KG 78.0 9.3 87.3 - 18 56.3 - 0.9 
6KG 74.8 13.4 88.1 3.3 66.5 2.35 
OKG 83.7 10.8 94.5 - 0.5 54.3 0.6 
OKL 82.0 9.7 91.7 0.5 63.9, 3.7 
8.5KG 71.8 22.3 94.0 - 0.4 470 - 49 
2OKG 79.8 14.8 94.5 - 0.4 44.5 4.8 
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EXAMPLE 2: Use of Multifunctional Macromers. 
30 g of a tetrafunctional water soluble PEG (MW 
18,500) (PEG 18.5k) was dried by dissolving the poly 
mer in benzene and distilling off the water benzene 5 
azeotrope. In a glove bag, 20g of PEG 18.5 k, 1.881 g 
of glycolide and 15 mg of stannous octoate were 
charged into a 100 ml round bottom flask. The flask was 
capped with a vacuum stopcock, placed into a silicone 
oil bath and connected to a vacuum line. The tempera 
ture of the bath was raised to 200 C. The reaction was 
carried out for 4 hours at 200 C. and 2 hours at 160 C. 
The reaction mixture was cooled, dissolved in dichloro 
methane and the copolymer was precipitated by pour 
ing into an excess of dry ethyl ether. It was redissolved 
in 200 ml of dichloromethane in a 500 ml round bottom 
flask cooled to 0°C. To this flask, 0.854 g of triethylam 
ine and 0.514 ml of acryloyl chloride were added under 
nitrogen atmosphere and the reaction mixture was 
stirred for 12 h. at 0° C. The triethyl amine hydrochlo 
ride was separated by filtration and the copolymer was 
recovered from filtrate by precipitating in diethyl ether. 
The polymer was dried at 50° C. under vacuum for 1 
day. 
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EXAMPLE 3: Synthesis of a Photosensitive Macromer 25 
containing DL-lactide. 
PEG (MW) 20,000) (PEG 20k) was dried by dis 
solving in benzene and distilling off the water benzene 
azeotrope. In a glove bag, 32.43 g of PEG 20k, 2.335g 
of DL-lactide and 15 mg of stannous octoate were 
charged into a 100 ml round bottom flask. The flask was 
capped with a vacuum stopcock, placed into a silicone 
oil bath and connected to a vacuum line. The tempera 
ture of the bath was raised to 200 C. The reaction was 
carried out for 4 hours at 200 C. The reaction mixture 
was cooled, dissolved in dichloromethane and the co 
polymer was precipitated by pouring into an excess of 
dry ethyl ether. It was redissolved in 200 ml of dichlo 
romethane in a 500 ml round bottom flask cooled to 0 40 
C. To this flask, 0.854 g of triethylamine and 0.514 ml of 
acryloyl chloride were added under nitrogen atmo 
sphere and the reaction mixture was stirred for 12 hours 
at 0°C. The triethylamine hydrochloride was separated 
by filtration and the copolymer was recovered from 
filtrate by precipitating in diethyl ether. The polymer 
was dried at 50° C. under vacuum for 1 day. 
EXAMPLE 4: Synthesis of a Photosensitive Precursor 
Containing DL-Lactide and e-Caprolactone. 
PEG (MW 600) (PEG 0.6k) was dried by dissolving 
in benzene and distilling off the water benzene azeo 
trope. In a glove bag, 0.973 g of PEG 0.6k, 0.467 g of 
DL-lactide along with 0.185g of e-caprolactone and 15 
mg of stannous octoate were charged into a 50 ml round 55 
bottom flask. The flask was capped with a vacuum 
stopcock, placed into a silicone oil bath and connected 
to a vacuum line. The temperature of the bath was 
raised to 200 C. The reaction was carried out for 4 
hours at 200 C. and 2 hours at 160 C. The reaction 60 
mixture was cooled, dissolved in dichloromethane and 
the copolymer was precipitated by pouring into an 
excess of dry ethyl ether. It was redissolved in 50 ml of 
dichloromethane in a 250 ml round bottom flask cooled 
to 0°C. to this flask, 0.854 g of triethylamine and 0.514 65 
ml of acryloyl chloride were added under nitrogen 
atmosphere and the reaction mixture was stirred for 12 
hours at O C. The triethyl amine hydrochloride was 
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separated by filtration and the copolymer was recov 
ered from filtrate by precipitating in diethyl ether. The 
polymer was dried at 50 C. under vacuum for 1 day 
and was a liquid at room temperature. 
EXAMPLE 5: Selection of Dyes for Use in 
Photopolymerization. 
It is possible to initiate photopolymerization with a 
wide variety of dyes as initiators and a number of elec 
tron donors as effective cocatalysts. Table 8 illustrates 
photopolymerization initiated by several other dyes 
which have chromophores absorbing at widely differ 
ent wavelengths. All gelations were carried out using a 
23% w/w solution of 18.5SKG in HEPES buffered 
saline. These initiating systems compare favorably with 
conventional thermal initiating systems, as can also be 
seen from Table 8. Other photoinitiators that may be 
particularly useful are 2-methoxy-2-phenyl acetophe 
none and camphorquinone. 
TABLE 8 
- Polymerization Initiation of 18.5KG PEG - 
TEMPER GEL 
LIGHT ATURE TIME 
NITIATOR SOURCE °C. (SEC) 
Eosin Y, 0.00015M; S. with UV 25 O 
Triethanolamine 0.65M filter 
Eosin Y, 0.00015M; S4 25 0. 
Triethanolamine 0.65M 
Methylene Blue, 0.00024M; S3 25 120 
p-toluenesulfinic acid, 
0.0048M 
2,2-dimethoxy-2-phenyl S2 25 8 
acetophenome 900 ppm 
Potassium persulfate 75 180 
0.068M 
Potassium Persulfate 25 120 
0.0168M; tetramethyl 
ethylene-diamine 0.039M 
Tetramethyl ethylene- S1 with UV 25 300 
diamine 0.039M; filter 
Riboflavia 0.0004M 
LIST OF LIGHT SOURCES USED 
CODE SOURCE 
S. Mercury lamp, LEITZ WETSLER Type 307-148.002, 
10OW 
S2 Black Ray longwave UV lamp, model B-100A 
WAFLOOD 
S3 MELLES GRIOT He-Ne laser, 10 mW output, 1 = 632 
S4 American laser corporation, argon ion laser, 
model 909BP-15-01001; A = 488 and 514 mm 
Numerous other dyes can be used for photopolymeri 
zation. These dyes include but are not limited to: Eryth 
rosin, phloxine, rose bengal, thioneine, camphorqui 
none, ethyl eosin, eosin, methylene blue, and riboflavin. 
The several possible cocatalysts that can be used in 
clude but are not limited to: N-methyl diethanolamine, 
N,N-dimethyl benzylamine, trierhanoi amine, triethyl 
amine, dibenzyl amine, N-benzyl ethanolamine, N-iso 
propyl benzylamine, and N-vinyl pyrrolidinone. 
EXAMPLE 6: Thermosensitive Biodegradable Gels 
from N-Isopropyl Acrylamide. 
Synthesis of low molecular weight polyisopropyl 
acrylamide. 
N-isopropyl acrylamide (NIPA Am) was recrystal 
lized from 65:35 hexane benzene mixture. Azobisisobu 
tyronitrile (AIBN) was recrystallized from methanol. 
1.5 g of NIPA Am was polymerized using 3 mg of 
AIBN and 150 mg of mercaptoethanol in 1:1 acetone 
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water mixture (24 hours at 65° C). The viscous liquid 
after polymerization was purified by dissolving in ace 
tone and precipitating in diethyl ether. Yield 80%. 
This hydroxy terminated low molecular weight 
poly(NIPA Am) was used in chain extension reactions 
using glycolide and subsequent endcapping reaction 
using acryloyl chloride as described in other examples. 
1 g of modified poly(NIPAAm) based oligomer and 
0.2 g 1KL were dissolved in water at 0° C. and polymer 
ized at 0° C. using 2-2-dimethoxy-2-phenylacetophe 
none (900 PPM). 
EXAMPLE 7: In Vitro Degradation 
The gels were extracted as described in Example 1 to 
remove the unpolymerized macromer fraction fraction 
and the gels were then placed in 50 mM HEPES buff 
ered saline (0.9% NaCl), pH 7.4 at 37° C. Duplicate 
samples were periodically removed, washed with fresh 
HBS and dried at 100° C. for 1 day and weighed to 
determine mass loss in the gel. The compositions of the 
various gels used were the same as described in the 
previous examples. Table 9 shows the extent of degra 
dation of these gels given as percent of mass lost over 
time. The respective times are given in parenthesis 
along with the mass loss data. 
TABLE 9 
Gel Degradation 
20.1% (1 d), 20.36 - 0.6 (2d), 21.7 -t (6d), 
28.8 - 16.6 (10 d) estimated total 
Degradation time 45 days. 
38.9 (ld), 60.3 + 4.2 (2d), 78.9 (3d), 
99.3 - 4.7 (6d). Total degradation time 5.5 
days. 
18.3 - 6.8 (ld), 27.4 - 1.0 (2d), 32.8 - 11.3 
(3d), 104.8 - 3.2 (5d). total degradation 
time 4.5 days 10KG 0.6 -- 0.6 (8 hr), 100 
(id). Total degradation time 1 day. 
10.0 - 4.84 (2d), 6.8 - 1.7 (3d), 4.5 h. 3.1 (6d), 
8.0 - 0.2 (10d). Total degradation time 
estimated to be 20 days. 
68.1 - 4.2 (8hr), 99.7 -- 0.3 (ld). Total 
degradation time 15 hr. 
1KG 
4KG 
6KG 
10KL 
20KG 
EXAMPLE 8: Fibroblast Adhesion and Spreading. 
The in vitro response of Human foreskin fibroblast 
(HFF) cells to photopolymerized gels was evaluated 
through cell culture on polymer networks. 0.2 ml of 
monomer solution was UV polymerized on an 18X18 
mm glass coverslips under sterile conditions. HFF cells 
were seeded on these gels at a cell density of 1.8x10 
cells/sq cm of coverslip area in Dulbecco's Modified 
Eagle's Medium (DMEM) supplemented with 10% 
fetal calf serum. The gels were incubated for 6 hr at 37 
C. in a 5% CO2 environment, at the end of which they 
were washed twice with phosphate buffered saline 
(PBS). The adherent cells were fixed using a 2% glutar 
aldehyde solution in PBS. The gels were examined 
under a phase contrast microscope at a magnification of 
200X, and the number of adherent and spread cells 
evaluated by examining five fields selected at predeter 
mined locations on the coverslips. 
The number of adherent cells is reported in Table 10 
along with those for glass control surfaces. Cell adhe 
sion is seen to be dramatically lowered on gel-coated 
glass. 
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TABLE 10 
Cell Adhesion 
Surface Attached Cells/cm 
glass 13220 - 3730 
18.5KG 250 - 240 
18.5KCL 1170 - 1020 
8.5KCO 390 - 150 
Typical photographs of these cells on the 18.5KCL 
gel surfaces and on control glass surfaces are shown in 
FIGS. 2A and 2B. It can be easily seen from Table 10 
that these gels are highly resistant to cellular growth. 
Even the 18.5KCL is still less than 10% of the glass. 
Cells attached to the glass surface show a flattened and 
well-spread morphology whereas the few cells that are 
attached to the gel are rounded and loosely attached. 
This may result from the fact that hydrated PEG chains 
have a high motility and have been shown to be effec 
tive in minimizing protein adsorption. One of the mech 
anisms by which cell adhesion is mediated is through 
the interaction of cell surface receptors with adsorbed 
cell adhesion proteins. Thus the reduction in overall 
protein adsorption results in minimal cell adhesion pro 
tein adsorption and reduced cell adhesion. 
EXAMPLE 9: Release of Protein (Bovine Serum 
Albumin) from Polymers. 
1KG was used for this study. This macromer was 
liquid at room temperature and was used as such. 1 mg 
of bovine serum albumin (BSA) was added per ml of 
monomer solution along with 0.9 mg/ml of 2,2-dime 
thoxy-2-phenyl-acetophenone as initiator. The protein 
was dissolved in the monomer solution and disc shaped 
gels were made by exposing 0.2 g of macromer mixture 
to LWUV for 1 min. Two such discs were placed in a 
flask containing 20 ml of PBS and incubated at 37 C. 
Two aliquots of 20 pull each were removed from these 
flasks periodically and the amount of BSA released was 
assayed using the Bio-Rad total protein assay. The re 
lease profile for BSA is shown in FIG. 3A. It can be 
seen that the release of BSA is relatively steady over 
more than a month. 
EXAMPLE 10: Enzyme Release Assay 
Water solubility of the macromers means gelation can 
be carried out in a non-toxic environment. This makes 
these materials suitable for intraoperative uses where in 
situ gelation is needed. Since the precursors are water 
soluble, the gels can be used as drug delivery vehicles 
for water soluble drugs, especially macromolecular 
drugs such as enzymes, which would otherwise be de 
natured and lose their activity. Release of lysosome and 
tPA from the polymers was used to illustrate the feasi 
bility of using biodegradable hydrogels for controlled 
release of biomolecules. 
Lysozyme Release 
The enzyme lysozyme (MW:14,400) is a convenient 
model for release of a low molecular weight protein 
from a biodegradable gel. The Biorad total protein 
assay was used to quantify the enzyme released. The 
enzyme was dissolved in PBS at a concentration of 20 
mg/ml. The monomer PEG-dl-lactic acid-diacrylate 
was dissolved in PBS to produce a 40% solution. The 
lysozyme solution was added to the monomer solution 
to attain a 24% monomer solution. The monomer/- 
lysozyme solution was polymerized under UV in a cy 
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lindrical mold, using 30 ul of the initiator 2,2-dime 
thoxy-2-phenyl-acetophenone in 1-vinyl-2-pyrrolidone 
(30 mg/ml) as the initiator. The polymer was cut into 10 
equal sized pieces and immersed in 10 ml PBS. Samples 
of the PBS were withdrawn at intervals and assayed for 
lysozyme released into the PBS. Lysozyme was re 
leased from the PEG-DL-lactic acid-diacrylate gel over 
an 8 day interval, with the maximum rate of release 
occurring within the first 2 days, as shown by FIG. 3B. 
Release of Recombinant t-PA 
Three macromers were used for these studies: 1KL, 
4KG, and 18.5KG. The 1KL macromer was liquid at 
room temperature and was used as such. The second 
macromer, 4KG, was used as a 75% w/w solution in 
PBS. The third composition was a mixture of equal 
parts of 1KL and a 50% w/w solution of 18.5KG. 3.37 
mg of tissue plasminogen activator (single chain, recom 
binant, M.W. 71,000) was added per gram of macroner 
solution along with 0.9 mg/ml of 2,2 dimethoxy 2 
phenyl acetophenone as initiator. The protein was dis 
solved with the macromer and disc shaped gels were 
made by exposing 0.2 g of macromer mixture to LWUV 
for 1 minute. Two such discs were rinsed with PBS, 
placed in a flask containing 5 ml of PBS and incubated 
at 37° C. Two aliquots of 100 ul each were removed 
from these flasks periodically and the amount of active 
t-PA released was assayed using a chromogenic Sub 
strate assay (Kabi-vitrum). The release profiles from the 
1K lactide gels, 4K glycolide gels, and the 50/50 1K 
glycolide/18.5K glycolide are shown in FIGS. 4A-4C. 
Fully active tRA can be released for periods up to at 
least two months. 
By selecting an appropriate formulation, the release 
rate can be tailored for a particular application. It is also 
possible to combine formulations with different molecu 
lar weights so as to synergistically achieve appropriate 
attributes in release and mechanical characteristics. 
For prevention of postoperative adhesions, in addi 
tion to the barrier effect of the gels, the gels can be 
loaded with a fibrinolytic agent to lyse incipient filny 
adhesions which escape the barrier effect. This further 
enhances the efficacy of biodegradable gels in adhesion 
prevention. 
EXAMPLE 11: Toxicity of Polymers and Commercial 
Adhesives. 
To evaluate the toxicity of in situ polymerization of 
the macromer solutions described herein, as compared 
to commercial adhesives, 100 ul of 18.5KCO prepoly 
mer solution was placed on the right lobe of a rat liver 
and gelled by exposing it to LWUV for 15 sec; simi 
larly, a few drops of a n-butyl cyanoacrylate based glue 
were placed on the left lobe. The liver was excised after 
a week, fixed in 10% neutral buffered formalin, blocked 
in paraffin, sectioned and stained using hematoxylin and 
OS 
No adverse tissue reaction was evident on the surface 
of the lobe exposed to the biodegradable gel. No inflam 
matory reaction to the polymerization process can be 
seen. The epithelium looks normal, with no foreign 
body reaction. 
In comparison, the lobe exposed to cyanoacrylate 
glue shows extensive tissue necrosis and scarring with 
10-30 cell deep necrotic tissue. Fibrosis is evident in the 
necrotic portions close to underlying normal tissue. 
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EXAMPLE 12: Prevention of Post-Surgical Adhesions 
with Photopolymerized Biodegradable Polymer. 
A viscous sterile 23% solution in phosphate buffered 
saline (8.0 g/1 NaCl, 0.201 g/1 KC, 0.611 g/1 Na2H 
PO4, 0.191 g/1 KH2PO4, pH 7.4) of polyethylene glycol 
(M.W. 18,500) which has been chain extended on both 
ends with a short polyglycolide repeat unit (average 
number of glycolidyl residues: 10 on each end) and 
which has been subsequently terminated with an acry 
late group was prepared. Initiator needed for the cross 
linking reaction, 2,2-dimethoxy-2-phenyl acetophenone, 
was added to the macromer solution to achieve an initi 
ator concentration of 900 ppm. A 30 second exposure to 
a long wave UV lamp (Blak Ray) is sufficient to cause 
polymerization. 
Animal Models Evaluated 
Animal models evaluated included a rat cecum model 
and a rabbit uterine horm model. In the rat cecum 
mode, 6 out of 7 animals treated with the macromer 
solution showed no adhesions whatsoever, while un 
treated animals showed consistent dense adhesion for 
mation. In the rabbit uterine horn model, a significant 
(p<0.01) reduction in adhesion formation was seen in 
the animals treated with the gel. Studies conducted in 
rats using only the ungelled viscous precursor solution 
(no LWUV) failed to prevent the formation of adhe 
SOS 
Rat Cecum Model 
Twenty-one Sprague Dawley male rats having an 
average weight of 250 gm were divided into three 
groups for treatment and two for controls. The abdo 
men was shaved and prepared with a betadine solution. 
A midline incision was made under Equithesin anesthe 
sia. The cecum was located and 4 to 5 scrapes were 
made on a region about 2X 1 cm on one side of the 
cecum, using a 4X4 in gauze pad to produce serosal 
injury and puncrate bleeding. The abdominal incisions 
in these animals were closed using a continuous 4-0 silk 
suture for the musculoperitoneal layer and 7.5mm stain 
less steel staples for the cutaneous layer. A topical anti 
biotic was applied at the incision site. 
The first group consisted of 7 animals serving as con 
trols without treatment, to confirm the validity of the 
model. The second group served as a control with the 
application of the precursor but without photopolymer 
ization to form the hydrogel. After induction of the 
0 cecal injury, about 0.25 ml of the precursor solution was 
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applied to the injury site using a piper. The abdominal 
incision was then closed as above. 
The third group served as the gel treatment group 
and was prepared as the second group except that the 
precursor film was exposed to a LWUV lamp for 45 
seconds to cause gelation. Both the obverse and reverse 
sides of the cecum were similarly treated with precursor 
and light. No attempt was made to dry the surface of the 
tissue, to remove blood, or to irrigate the area prior to 
treatment. 
The animals were sacrificed at the end of two weeks 
by CO2 asphyxiation. The incisions were reopened and 
adhesions were scored for location, extent, and tenacity. 
The extent of adhesions was reported as a percentage of 
the traumatized area of the cecum which forms adhe 
sions with adnexal organs or the peritoneal wall. Tenac 
ity of the adhesions was scored on a scale from 0 to 4: no 
adhesions-grade 0; tentative transparent adhesions 
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Which frequently separate on their own-grade 1; ad 
hesions that give some resistance but can be separated 
by hand-grade 2; adhesions that require blunt instru 
ment dissection to separate-grade 3; and dense thick 
adhesions which require sharp instrument dissection in 
the plane of the adhesion to separate-grade 4. 
Rat Cecum Model Results 
The control group without treatment shows consis 
tently dense and extensive adhesions. The extent of 
abraded area covered with adhesions was seen to be 
73-21% (mean-tS.D., n = 7). The severity of adhe 
sions was grade 3.5-0.4. Most of the adhesions were 
dense and fibrous, involving the cecum with itself, with 
the peritoneal wall and with other organs such as the 
liver, small intestine, and large intestine. Frequently the 
nesentery was seen to be involved in adhesions. In the 
control group with the application of precursor solution 
but without gelation by exposure to the LWUV lamp, 
the extent of adhesion was 60.24% (n=7), and the 
severity of adhesions was 3.1-0.4. In the gel treated 
group, the cecum was seen to be completely free of 
adhesions in 6 out of 7 animals. In one case, a grade 2 
adhesion was seen with the mesentery over 10% of the 
area and a grade 2.5 adhesion was seen over 15% of the 
area, bridging the cecum to the sutures on the site of the 
incision in the peritoneal wall. The overall adhesion 
extent for the group was 4%, and the overall severity 
was 0.32. No evidence of residual gel was visible, the 
gel presumably having degraded within the prior two 
weeks. The cecum appeared whitish with a fibrous 
layer on the surface in the control group, but the tissue 
appeared healthy and normal in animals treated with the 
gel. 
Rabbit Uterine Horn Model 
Eight sexually mature female New Zealand rabbits 
between 2 and 3 kg in weight were prepared for sur 
gery. A midline incision was made in the lower abdomi 
nal region under Rompun, Ketamine, and Aceprona 
zine anesthesia. The uterine horns were located and the 
vasculature to both horns was systematically cauterized 
to induce an ischemic injury. One animal was rejected 
from the study due to immature uterine horns. Seven 
rabbits were selected for the treatment with only the 
photopolymerizable hydrogel and two animals were 
selected for evaluating the combined efficacy of the 
hydrogel with a fibrinolytic agent, tissue plasminogen 
activator (tPA). 5 mg of t?A/ml macromer solution 
was used in the latter case. After cauterization, na 
cromer solutions (0.5 ml) were applied along the horn 
and allowed to coat the surface where the cauterization 
injury had been induced. After uniform application of 
the solution was complete, the horns were exposed to a 
LWUV lamp for 1 min to induce gelation. The proce 
dure was repeated on the reverse side of the horns. The 
incisions were then closed using a continuous 2-0 Vicryl 
(Ethicon) suture for the musculoperitoneal layer and a 0 
Vicryl (Ethicon) suture for the cutaneous layer. No 
prophylactic antibiotics were administered. No postop 
erative complications or infections were observed. Five 
animals were used in the control group. The ischemic 
injury was made as described and the incision was 
closed without the application of the precursor; all 
techniques were identical between the treatment group 
and the control group. 
Controls were used where the same animal model 
was subjected to surgery without application of the 
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macromer; all surgical techniques were identical be 
tween the treatment group and the historical controls. 
The rabbits were reoperated under Ketamine anes 
thesia at the end of two weeks to evaluate adhesion 
formation; they were sacrificed by introcardiac KCl 
injection. Adhesion formation was evaluated for extent 
and tenacity. Extent of adhesion formation was evalu 
ated by measuring the length of the uterine horn that 
formed adhesions with itself or with the peritoneal wall 
or other organs. Tenacity of adhesion was classified as 
either filmy or fibrous. Filmy adhesions were usually 
transparent, less strong, and could be freed by hand. 
The fibrous adhesions were dense, whitish, and usually 
required sharp instrument dissection to be freed. In 
cases where only a single filmy adhesion band was evi 
dent, a score of 5% was assigned. 
Typical samples of the horn were excised for histol 
ogy and were fixed in a 10% neutral buffered formalin 
solution. Paraffin sections of the samples were stained 
using hematoxylin and eosin. 
Rabbit Uterine Horn Model Results 
The adhesion score is the % of affected area occupied 
by the adhesions, with grading of each as being filmy or 
fibrous. Distorted horn anatomies were observed in 
control animals. The mean score in the control group 
was 50-15% of the affected area of the horn being 
occupied by adhesions with 10% of these being filmy 
and 90% fibrous. Distorted horn anatomies were ob 
served, as can be seen from FIG. 5A which presents a 
superior view of the uterine horn in an animal used as a 
control, which showed adhesions over 66% of the horn 
surface. The group of animals treated only with the 
photopolymerized macromer showed an adhesion score 
of 13-11.4% (n=10). Of these, 4 animals showed less 
than 5% adhesions with only an occasional filmy band 
visible. 
The animals treated with photopolymerized gel con 
taining tPA showed further improved results over the 
“gel only' animals. One animals showed a filmy band 
on both the right and left horn. They were assigned a 
score of 5% with a total score of 10%. The other animal 
did not show any adhesions at all. Thus the total score 
for these animals was 5H5%. 
FIG. 5B shows normal horn anatomy in a typical 
horn which has undergone gel treatment. Adhesions are 
filmy in all cases and no dense bands are seen. No traces 
of the remaining gel could be observed. Typical samples 
of horns showing filmy adhesions showed some fibrous 
tissue with a 6-15 cell thick layer of fibroblasts showing 
some collagen fibrils but no formation of dense collagen 
fibers. The horns showing no adhesions occasionally 
showed a 1-4 cell thick layer of fibroblasts, but mostly a 
normal epithelium with no evidence of inflammatory 
cells. 
This same procedure was slightly modified as de 
scribed below as a better mode of using the polymers to 
prevent postoperative adhesions using the rat uterine 
horn model. 
Female rats were anesthetized with pentobarbital (50 
mg/kg, intraperitoneally), and a midline laparotomy 
was performed. The uterine horns were exposed, and 
the vasculature in the arcade feeding the horns was 
systematically cauterized using bipolar cautery; the 
most proximal and most distal large vessel on each horn 
were not cauterized. Following this, the antimesenteric 
surface of eachhorn was cauterized at two 1 mm diame 
ter spots on each horn, each separated by a 2 cm dis 
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tance, the pair centered along the length of each horn. 
Following injury, 0.5 ml of macromer solution was 
applied per horn and was gelled by exposure to long 
wavelength ultraviolet light (365 nm, approximately 20 
mW/cm2) for 15 sec per surface on the frontside and on 
the back side each. The uterus was replaced in the peri 
toneal cavity, and the musculoperitoneal and skin layers 
were closed. 
The macromer consisted of a PEG chain of MW 
8,000 daltons, extended on both sides with a lactic acid 
oligomer of an average degree of polymerization of 5 
lactidyl groups, and further acrylated nominally at both 
ends by reaction with acryloyl chloride. In one batch, 
Batch A, the degree of acrylation was determined by 
NMR to be approximately 75%, and in another, Batch 
B, it was determined to be greater than approximately 
95%. The macromer was dissolved in saline at a speci 
fied concentration, and the initiation system used was 
2,2-dimethoxy-2-phenyl acetophenone from a stock 
solution in N-vinyl pyrrolidinone, the final concentra 
tion of 2,2-dimethoxy-2-phenyl acetophenone being 900 
ppm and the final concentration of N-vinyl pyrrolidi 
none being 0.15%. 
In one set of experiments, macromer from Batch A 
was applied in varying concentrations, and adhesions 
were scored at 7 days postoperatively. Scoring was 
performed by two means. The length of the horns in 
volved in adhesions was measured with a ruler, and the 
fraction of the total length was calculated. The nature 
of the adhesions was also scored on a subjective scale, 0 
being no adhesions, 1 being filmy adhesions that are 
easily separated by hand, and 2 being dense adhesions 
that can only be separated by sharp instrument dissec 
tion. Furthermore, one of the samples contained tissue 
plasminogen activator (t-PA), which is known to re 
duce adhesions, at a concentration of 0.5 mg/ml (0.5%) 
macromer solution. The results are shown in Table 11 
for macromer batch A and batch B. 
In a third set of experiments, adhesions were formed 
in female rats as described above, and the adhesions 
were surgically lysed 7 days after the initial surgery. 
The extent and grade of adhesions was scored during 
lysis. The animals were divided into two groups, and 
one group was treated with macromer from Batch Bat 
a concentration of 10%. The results are shown in Table 
11 as batch B, 10%. 
TABLE 11 
Reduction of Adhesions with Polymer. 
Extent of Grade of 
Concentration adhesions adhesions Number of 
2COle % (S.D.) (0-2) Animals 
Polymer A - 
15% 24.6 (3.1) 1.1 (0.1) 7 
20% 33.6 (9.8) 1.2 (0.3) 7 
25% 37.5 (11.1) 1.2 (0.1) 7 
30% 54.2 (12.0) 1.6 (0.4) 6 
20% -- t-PA 18.3 (6.4) 1.1 (0.1) 6 
Control (saline) 72.6 (18.7) 1.5 (0.2) 7 
Polymer B. 
5% 22.1 (4.2) 1.2 (0.1) 7 
10% 10.0 (5.1) 1.0 (0) 7 
15% 17.8 (5.7) 1.0 (0) 7 
20% 26.3 (114) 1.4 (0,2) 7 
Control (saline) 759 (4.4) 1.8 (0.3) 7 
Polymer B, 10% 
Scoring group 
performed that 
at: became: 
time of Controls 85.9 (9.7) 1.8 (0.1) 7 
lysis 
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TABLE 11-continued 
Reduction of Adhesions with Polymer. 
Extent of Grade of 
Concentration adhesions adhesions Number of 
3CO6 % (S.D.) (0-2) Animals 
Time of Treatment 79.4 (6.8) 1.7 (0.2) 7 
lysis 
7 days Controls 78.8 (11.3) 1.8 (0.1) 7 
post-lysis 
7 days Treatment 28.2 (5.1) 1.0 (0) 7 
post-lysis 
The above results illustrate that the photopolymer 
ized macromer can reduce or prevent post operative 
adhesions in both primary adhesions and adhesiolysis 
models, and moreover that the gel can be used to locally 
release a drug to exert a combined beneficial effect. 
EXAMPLE 13: Nerve Anastomosis. 
The sciatic nerve of a rat was aseptically severed 
using a scalpel and allowed to pull apart. The two ends 
of the nerve were reopposed using sterile forceps, and a 
50% solution in buffer of polymer 1KL, a macromer 
made from PEG 1K with lactide chain extension and 
acrylate termination, with 0.1%. 2,2-dimethoxy-2- 
phenoxy acetophenone was applied to the nerve 
stumps. The affected area was illuminated with a 100 W 
LWUV lamp for 60 seconds, and an adhesive bond was 
observed to form between the proximal and distal nerve 
stumps. 
To ensure the biocompatibility of the applied material 
with the nerve tissue, the same solution of macromer 
was applied to nonsevered rat sciatic nerves, and the 
area of the incision was closed using standard small 
animal surgical technique. The area was reopened at 1 
hour or 24 hour postoperatively, and the affected area 
of the nerve was removed en block and prepared for 
transmission electron microscopy. No morphological 
differences were observable between the treated nerves 
at either time point as compared to control rat sciatic 
nerves that were otherwise nonmanipulated, even 
though they had been traumatized and manipulated. 
EXAMPLE 14: Evaluation of PEG Based Degradable 
Gels as Tissue Adhesives. 
Abdominal muscle flaps from female New Zealand 
white rabbits were excised and cut into strips 1 cm×5 
cm. The flaps were approximately 0.5 to 0.8 cm thick. A 
lap joint, 1 cm× 1 cm, was made using two such flaps. 
Two different compositions, 0.6KL and 1 KL, were 
evaluated on these tissues. Both these compositions 
were viscous liquids and were used without further 
dilution. 125 ul of ethyl eosin solution in N-vinyl pyr 
rolidone (20 mg/ml) along with 50 ul of triethanol 
amine was added to each ml of the adhesive solution. 
100 ul of adhesive solution was applied to each of the 
overlapping flaps. The lap joint was then irradiated by 
scanning with a 2 W argon ion laser for 30 sec from 
each side. The strength of the resulting joints was evalu 
ated by measuring the force required to shear the lap 
joint. One end of the lap joint was clamped and an 
increasing load was applied to the other end, while 
holding the joint was clamped and an increasing load 
was applied to the other end, while holding the joint 
horizontally until it failed. Four joints were tested for 
each composition. The 1KL joints had a strength of 
6.6-1.0 KPa (mean-ES.D.), while the 0.6KL joints had 
a strength of 11.4-2.9KPa. It is significant to note that 
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it was possible to achieve photopolymerization and 
reasonable joint strength despite the 6-8 mm thickness 
of tissue. A spectrophotometric estimate using 514 nm. 
light showed less than 1% transmission through such 
muscle tissue. 
EXAMPLE 15: Coupling of Photopolymerizable 
Groups to Proteins (Albumin). 
PEG (M.W. 2,000) monoacrylate (5 g) was dissolved 
in 20 ml dichloromethane. Triethyl amine (0.523 g) and 
2,2,2-trifluoroethanesulfonyl chloride (tresyl chloride) 
(0.017 g) were added and the reaction was allowed to 
proceed for 3 hours at 0°C. under nitrogen atmosphere. 
The reaction mixture was then filtered and the dichloro 
methane evaporated to dryness. The residue was redis 
solved in a small amount of dichloromethane and pre 
cipitated in diethyl ether. The polymer was then filtered 
and dried under vacuum for 10 hours and used directly 
in the subsequent reaction with albumin. 
1 g of bovine serum albumin was dissolved in 200 ml 
of sodium bicarbonate buffer at pH 9. Tresyl activated 
PEG monoacrylate (5 g) was added and the reaction 
was stirred for 24 hours at 25 C. Albumin was sepa 
rated by pouring the reaction mixture into acetone. It 
was further purified by dialysis using a 15,000 daltons 
cutoff dialysis membrane. A 10% w/v solution of the 
PEG acrylated albumin could be photopolymerized 
with long wave UV radiation using 0.9 mg/ml of 2,2 
dimethoxy 2 phenylacetophenone as the initiator. In this 
gel the degradable segment is the protein albumin. 
EXAMPLE 16: Modification of Polysaccharides 
(Hyaluronic Acid) 
In a dry 250 ml round bottom flask, 10 grams of PEG 
400 monomethacrylate was dissolved in 100 ml dry 
dioxane, to which 4,053 g of carbonyl diimidazole 
(CDI) was slowly introduced under nitrogen atmo 
sphere and the flask was heated to 50 C. for 6h. There 
after the solvent was evaporated under vacuum and the 
CDI activated PEG monomer was purified by dis 
solving in dichloromethane and precipitating in ether 
twice. 
1 g of hyaluronic acid, 5g of CDI activated PEG 400 
monoacrylate were dissolved in 200 ml sodium borate 
buffer (pH 8.5) and the solution was stirred for 24 hours. 
It was then dialyzed using a 15,000 dalton cutoff dialysis 
membrane to remove unreacted PEG. A 10% w/v 
solution of the acrylated hyaluronic acid was photopo 
lymerized with long wave UV radiation, using 0.9 
mg/ml of 2,2-dimethoxy-2-phenylacetophenone as the 
initiator. In this gel, the degradable region is hyaluronic 
acid. 
EXAMPLE 7: PEG Chain Extended with 
Polyorthocarbonates and Capped with Urethane 
Methacrylate. 
3,9-bis(methylene) 2,4,8,10-tetraoxaspiro 5,5 unde 
cane (1 g) and polyethylene glycol (molecular weight, 
1,000, 7.059 g) were weighed into a 250 ml Schlenk tube 
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under dry nitrogen atmosphere in a glove bag. 50 ml of 60 
dry tetrahydrofuran was introduced under nitrogen 
atmosphere and reaction mixture was stirred for 6 hours 
at 50° C. This is a typical step growth reaction with a 
disturbed stoichiometry, resulting in low molecular 
weight poloyorthocarbonate with terminal hydroxy 
groups. The oligomer was separated by precipitating in 
hexane and dried under vacuum. 5 g of oligomer was 
redissolved in dry THF to which 20 ul of dibutyltin 
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dilaurate and 2 ml of 2-isocyanatoethyl methacrylate 
were slowly introduced and temperature was raised to 
50° C. It was held there for 6 hours and cooled. The 
product was separated by precipitation in hexane. In 
this gel, the degradable region is a polyorthocarbonate. 
EXAMPLE 18: Microencapsulation of Animal Cells. 
A 23% w/w solution of 8.5KG in HEPES buffered 
saline (5 ml) was used to resuspend 106 CEM-SS cells. 
Ethyl ecosin (10M) was used as a solution in N-vinyl 
pyrrolidone as the initiator and triethanolamine (0.01 
M) was used as the coinitiator. The solution was then 
exposed through a coextrusion apparatus to an argon 
ion laser (514 nm, 2 Watts). The coextrusion apparatus 
had mineral oil as the fluid flowing annularly (flow rate 
4 ml/min) around an extruding stream ef the precursor 
cell suspension (flow rate 0.5 ml/min). The microdrip 
lets gelled rapidly on being exposed to the laser light 
and were collected in a container containing PBS. The 
oil separated from the aqueous phase and the micro 
spheres could be collected in the PBS below. The mi 
crospheres formed were thoroughly washed with PBS 
buffer to remove unreacted monomer and residual initi 
ator. The size and shape of microspheres was dependent 
on extrusion rate and extruding capillary diameter (18 
Ga to 25 Ga). The polymerization times were depen 
dent on initiator concentration (ethyl edsin 5uM to 0.5 
mM, vinyl pyrrollidone (0.001% to 0.1%), and trietha 
nolamine (5 mM to 0.1 M), laser power (120 mW to 2 
W), and monomer concentration (>10%w/v). Spheres 
prepared using this method had a diameter from 500 um 
to 1,200 um. The polymerizations were carried out at 
physiological pH in the presence of air. This is signifi 
cant since radical polymerizations may be affected by 
the presence of oxygen. Cell viability subsequent to 
encapsulation was checked by trypan blue exclusion 
assay and the encapsulated cells were found to be more 
than 95% viable after encapsulation. 
EXAMPLE 19: Various Formulations for the 
Prevention of Post Operative Adhesions. 
The utility of PEG-oligo(a-hydroxy acid) diacrylates 
and tetraacrylates to prevent postoperative adhesions 
was evaluated in the rabbit uterine horn model as de 
scribed above. The following polymers were synthe 
sized, as described above: PEG 6K lactide diacrylate 
(6KL), PEG 10K lactide diacrylate (10KL). PEG 
18.5K lactide (18.5KL), PEG 20K lactide (20KL). So 
lutions with 24% polymer in PBS with 900 ppm 2,2- 
dimethoxy-2-phenyl acetophenone, were prepared as 
described above. The solutions were applied to the 
uterine horn after cautery of the vascular arcade and 
illuminated with a 365 nm LWUV lamp, as described 
above. In one formulation, 18.5KL, 5 mg t-PA was 
mixed into the solution before application. Controls 
consisted of animals manipulated and cauterized but not 
treated with macromer solution. Measurement was per 
formed on the 14th-E1 day. Extent of adhesion was 
estimated from the fraction of the horn that was in 
volved in adhesions, and the tenacity of adhesions was 
scored as 0, no adhesions; 1, filmy adhesions that offer 
no resistance to dissection; 2, fibrous adhesions that are 
dissectable by hand; 3, fibrous adhesions that are dis 
sectable by blunt instruments; and 4, fibrous adhesions 
that are dissectable by sharp instruments. The results 
were as follows, where the extent of adhesions and the 
tenacity of the adhesions are shown. 
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TABLE 2 
Efficacy of Polymer in Preventing Adhesions. 
Number Extent, 26, Tenacity, 
Formulation of animals S.D. 0-4 S.D. 
6KL 7 0.9 - 1. O.9 0.7 
10KL 7 0 - O 0 - O 
20KL 6 44 5.0 0.9 0.7 
18.5K. 7 8.9 13.1 1.6 1.3 
t-PA 
Control 7 35 - 22 3.3 - 0.6 
EXAMPLE 2.0: Polymerization of Ultrathin Layers of 
Polymer on the Surface of Blood Vessels to Reduce 
Thrombosis After Vessel Injury. 
Blood vessels were harvested from rats and were 
rinsed free of blood. The endothelium of the vessel were 
removed by inserting a wooden dowel and rotating the 
vessel over the dowel. One vessel was used as a control, 
and was exposed to flowing blood as described below 
without further modification. Another vessel was 
treated first by exposure to eosin Y at 1 mM in saline, 
then rinsed in HEPES buffered saline, then filled with a 
solution of PEG-MA, PEG 10K with acrylate end 
capped oligomers of DL lactide, containing triethanol 
amine (TEA) (100 mM) and N-vinylpyrrolidone (VP) 
(0.15%) and then illuminated by exposure to an argon 
ion laser at 0.5 W/cm2 for 15 sec. The nonpolymerized 
prepolymer mixture in the lumen of the vessel was 
rinsed away with saline. Human blood was collected 
from the antecubital vein and was anticoagulated with 
heparin at 2 units/mi. This blood was perfused through 
each vessel by a syringe pump at a flow rate corre 
sponding to a wall shear rate of approximately 200/s for 
7 min. The vessel was then superficially rinsed in saline 
and fixed in formaldehyde. 
The treated vessel did not appear colored or different 
in color after perfusion compared to its color before 
perfusion, while the untreated control vessel appeared 
blood red. Thin segments of each vessel were cut from 
each vessel, were mounted on end, and were examined 
by environmental scanning electron microscopy 
(ESEM). ESEM is performed on hydrated samples in 
relatively low vacuum. This permits the visualization of 
the polymer film coating in the swollen and wet state. 
This is important to obtain measurements that may be 
readily interpreted, since the polymer film is approxi 
mately 95% water. A high degree of thrombosis was 
readily observed in the control vessel. The lumen of this 
vessel was narrowed to less than one-third its diameter 
pre-perfusion by the accumulation of thrombus, as 
shown in FIG. 6A. By contrast, no thrombus could be 
observed in the lumen of the treated vessel, as shown in 
FIG. 6B. A higher magnification of the vessel wall 
demonstrated no adherent thrombus. A still higher 
magnification shows a white structure which is the 
polymer film, which is different in contrast from the 
tissue due to differential charging under the electron 
beam of the ESEM. The film may be seen to be pre 
cisely conformed to the shape of the vessel and be ap 
proximately 5-8 pum thick. 
The region of polymerization was restricted to the 
neighborhood of the blood vessel wall surface. The 
photosensitive dye was adsorbed to the vessel wall. 
Unbound dye was rinsed away. The entire lumen was 
filled with prepolymer, but upon illumination the gel 
formation was restricted to the vessel wall where the 
dye and the prepolymer meet. This interfacial polymeri 
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zation process can be conducted to produce surface 
adherent layers that vary in thickness from less than 7 
um to more than 500 um. 
The above procedure was performed in 8 control rat 
arteries, and 8 treated arteries, with equivalent light 
microscopic histological results as described above. AS 
demonstrated by this study, PEG prepolymers can be 
polymerized upon the lumenal surface of blood vessels. 
The immediate effect of this modification is to reduce 
the thrombogenicity of an injured blood vessel surface. 
This has clear utility in improving the outcome of bal 
loon angioplasty by reducing the thrombogenicity of 
the vessel and lesion injured by balloon dilation. An 
other effect of this modification is to be reduce smooth 
muscle cell hyperplasia. This may be expected for two 
reasons. First, platelets contain a potent growth factor, 
platelet-derived growth factor (PDGF), thought to be 
involved in postangioplasty hyperplasia. The interrup 
tion of the delivery of PDGF itself poses a pharmaco 
logical intervention, in that a "drug' that would have 
been delivered by the platelets would be prevented 
from being delivered. Thrombosis results in the genera 
tion of thrombin, which is a known smooth muscle cell 
mitogen. The interruption of thrombin generation and 
delivery to the vessel wall also poses a pharmacological 
intervention. There are other growth factors soluble in 
plasma which are known to be smooth muscle cell mito 
gens. The interruption of thrombin generation and de 
livery to the vessel wall also poses a pharmacological 
intervention. Moreover, there are other growth factors 
soluble in plasma which are known to be smooth muscle 
cell mitogens. The gel layer is known to present a 
permselective barrier on the surface of the tissue, and 
thus the gel layer may reasonably be expected to reduce 
hyperplasia after angioplasty. The inhibition of throm 
bosis upon the vessel wall may also reduce the inci 
dence of abrupt reclosure and vasospasm, both of which 
occur sometimes following vascular intervention. 
EXAMPLE 21: Interfacial Polymerization of 
Macromers Inside Blood Vessels to Prevent 
Thrombosis. 
Macromet solutions were polymerized interfacially 
within previously injured blood vessels in vivo to pre 
vent thrombosis. The carotid artery was exposed, and a 
polyethylene tube (PE-10) was used to cannulate the 
exterior carotid artery. The artery was clamped with 
fine arterial clamps proximal to the interior/exterior 
carotid artery bifurcation and approximately 2 cm distal 
to the bifurcation. A 1 ml tuberculin syringe was used to 
rinse the blood from the lumen of the isolated Zone by 
filling and emptying the vessel Zone. The vessel was 
injured by crushing using a hemostat. The isolated Zone 
was filled with a 10 mM solution of eosin Y for 2 min 
utes, after which it was rinsed and filled with a 20% 
solution of a macromer in saline with 0.1 mM triethanol 
amine and 0.15% N-vinyl pyrrolidinone. The macromet 
consisted of a PEG chain of MW 8,000 daltons, ex 
tended on both sides with a lactic acid oligomer of an 
average degree of polymerization of 5 lactidyl groups, 
and further acrylated nominally at both ends by reac 
tion with acryloyl chloride. The vessel was illuminated 
transmurally using an argon ion laser (514 nm) at an 
intensity of approximately 1 mW/cm2 for 5 seconds. 
Following this, the cannula was removed from the exte 
rior carotid artery and the artery was ligated at the 
bifurcation. The arterial clamps were removed to per 
mit the resumption of blood flow. Perfusion was al 
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lowed for 20 minutes, following which the vessel were 
again isolated, removed from the body, gently rinsed, 
fixed, and prepared for light microscopic histological 
analysis. Using the naked eye, the crushed segments in 
control animals, which lacked illumination, were red, 
indicating internal thrombus with entrapped red blood 
cells. By contrast, no redness was observed at the site of 
the crush injury in the treated vessels. Histology 
showed extensive thrombus, fibrin, and entrapped red 
blood cells in the non-treated vessels. By contrast, no 
thrombus or fibrin or entrapped red blood cells were 
observed in the treated vessels. The procedure was 
conducted in four control animals and three treated 
animals. 
This example demonstrates that the polymerization 
can be carried out in situ in the living animal, that the 
polymer coating remains adherent to the vessel wall 
during arterial blood flow, and that the polymer coating 
can prevent thrombosis in vivo in non-anticoagulated 
animals. This approach to treatment has clear benefits in 
preventing abrupt reclosure, vasospasm, and restenosis 
after intravascular interventional procedures. More 
over, it is more generally applicable to other intralu 
minal and open-surface organs to be treated. 
Modifications and variations of the present invention, 
the macromer and polymeric compositions and meth 
ods of use thereof, will be obvious to those skilled in the 
art from the foregoing detailed description. Such modi 
fications and variations are intended to come within the 
scope of the appended claims. 
We claim: 
1. A biodegradable, polymerizable macromer having 
a solubility of at least about 1 g/100 ml in an aqueous 
solution comprising at least one water soluble region, at 
least one degradable region which is hydrolyzable 
under in vivo conditions, and free radical polymerizable 
end groups having the capacity to form additional cova 
lent bonds resulting in macromer interlinking, wherein 
the polymerizable end groups are separated from each 
other by at least one degradable region. 
2. The macromer of claim 1 wherein the water solu 
ble region is attached to a degradable region, at least 
one polymerizable end group is attached to the water 
soluble region, and at least one polymerizable end 
group is attached to the degradable region. 
3. The macromer of claim 1 wherein the water solu 
ble region forms a central core, at least two degradable 
regions are attached to the core, and the polymerizable 
end groups are attached to the degradable regions. 
4. The macromer of claim 2 wherein the degradable 
region is a central core, at least two water soluble re 
gions are attached to the core, and a polymerizable end 
group is attached to each water soluble region. 
5. The macromer of claim 1 wherein the water solu 
ble region is a macromer backbone, the degradable 
region is a branch or graft attached to the macromer 
backbone, and polymerizable end groups are attached 
to the degradable regions. 
6. The macromer of claim 1 wherein the degradable 
region is a macromer backbone, the water soluble re 
gion is a branch or graft attached to the degradable 
backbone, and polymerizable end groups are attached 
to the water soluble branches or grafts. 
7. The macromer of claim 1 wherein the water solu 
ble region is a star backbone, the degradable region is a 
branch or graft attached to the water soluble star back 
bone, and at least two polymerizable end groups are 
attached to a degradable branch or graft. 
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8. The macromer of claim 1 wherein the degradable 
region is a star backbone, the water soluble region is a 
branch or graft attached to the degradable star back 
bone, and two or more polymerizable end groups are 
attached to the water soluble branch or graft. 
9. The macromer of claim 1 wherein the water solu 
ble region is also the degradable region. 
10. The macromer of claim 1 wherein the water solu 
ble region is also the degradable region, one or more 
additional degradable regions are grafts or branches 
upon the water soluble region. 
11. The macromer of claim 1 comprising a water 
soluble core region, at least two degradable extensions 
on the core, and an end cap on at least two of the de 
gradable extensions, wherein 
the core comprises poly(ethylene glycol); 
each extension comprises biodegradable poly(a- 
hydroxy acid); and 
each end cap comprises an acrylate oligomer or mon 
Ole. 
12. The macromer of claim 11 wherein 
each extension comprises biodegradable poly(hy 
droxy acid); and 
each end cap comprises an acrylate oligomer or mon 
Oe. 
13. The macromer of claim 12 wherein the poly(ethy 
lene glycol) has a molecular weight between about 400 
and 30,000 Da; 
the poly(hydroxy acid) oligomers have a molecular 
weight between about 200 and 1200 Da; and 
the acrylate oligomer or monomer have a molecular 
weight between about 50 and 200 Da. 
14. The macromer of claim 1 wherein the polymeriz 
able end groups contain a carbon-carbon double bond 
capable of cross-linking and polymerizing macromers. 
15. The macromer of claim 1 wherein crosslinking 
and polymerization of the macromer can be initiated by 
a light-sensitive free-radical polymerization initiator 
with or without a cocatalyst, further comprising a free 
radical polymerization initiator. 
16. The macromer of claim 15 wherein the initiator is 
selected from the group consisting of xanthine dyes, 
acridine dyes, thiazine dyes, phenazine dyes, camphor 
quinone dyes, and acetophenone dyes. 
17. The macromer of claim 16 wherein the initiator is 
selected from the group consisting of an eosin dye with 
triethanolamine, 2,2-dimethyl-2-phenyl acetophenone, 
and 2-methoxy-2-phenyl acetophenone. 
18. The macromer of claim 1 wherein crosslinking or 
polymerizations can be initiated in situ by light having a 
wavelength of 320 nm or longer. 
19. The macromer of claim 1 wherein the degradable 
region is selected from the group consisting of poly 
(hydroxy acids), poly(lactones), poly(amino acids), po 
ly(anhydrides), poly(orthoesters), poly(phosphazines), 
and poly(phosphoesters). 
20. The macromer of claim 19 wherein the degrad 
able region is a poly(a-hydroxy acid) selected from the 
group consisting of poly(glycolic acid), poly(DL-lactic 
acid) and poly(L-lactic acid). 
21. The macromer of claim 19 wherein the poly(lac 
tone) is selected from the group consisting of poly(e- 
caprolactone), poly (6-valerolactone) or poly(w- 
butyrolactone). 
22. The macromer of claim 1 wherein the water solu 
ble region is selected from the group consisting of poly 
(ethylene glycol), poly(ethylene oxide), poly(vinyl al 
cohol), poly(vinylpyrrollidone), poly(ethyloxazoline), 
5,410,016 
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poly(ethylene oxide)-copoly(propyleneoxide) block consisting of proteins, carbohydrates, nucleic acids, 
copolymers, polysaccharides, carbohydrates, proteins, 
and combinations thereof. s o 
23. The macromer of claim 1 further comprising cules, cells, tissues, and tissue aggregates. 
biologically active molecules selected from the group 5 it k k k sk 
organic molecules, inorganic biologically active mole 
O 
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